Cicutto 2005.
Methods | STUDY DESIGN: Cluster‐randomised controlled trial
LOCATION, NUMBER OF CENTRES: Canada, 26 schools
DURATION OF STUDY: 12 months Outcome assessors were blinded to treatment group allocation |
|
Participants | N SCREENED: Not reported N RANDOMISED: 129 children from 256 randomised had experienced an ED visit within previous year. Demographics taken from total cohort (treatment: 132; control: 124) N COMPLETED: 239 (treatment: 121; control: 118) M = 151 F = 105 MEAN AGE: 8.6 BASELINE DETAILS: 70% children had mild asthma INCLUSION CRITERIA: Enrolled in Grade 2 to 5, spoke English, given consent/assent, report of physician diagnosed asthma, asthma medication use, asthma symptoms 3 or more times in past year EXCLUSION: Presence of 2nd major chronic illness with pulmonary component | |
Interventions | EDUCATION GROUP: Six 60‐minute group sessions based on Roaring Adventures of Puff (RAP). The sessions include the following: (1) getting to know each other, goal setting, use of a peak flowmeter and diary monitoring; (2) trigger identification, control and avoidance, and basic pathophysiology; (3) medications and the proper use of inhalers; (4) symptom recognition and action plan use; (5) lifestyle, exercise and managing an asthma episode; and (6) sharing asthma information with teachers and parents. Teaching strategies include puppetry, games, role playing, model building, discussions and asthma diary recordings. Parental involvement is encouraged through the use of asthma‐related homework activities for the family during the weekly intervals. Intervention delivered by health educators. Setting: School CONTROL GROUP: Usual care TREATMENT PERIOD: 6 weeks FOLLOW‐UP PERIOD: 12 months |
|
Outcomes | Quality of life; school absence; parental work absence; health services use | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Adequate sequence generation? | Low risk | Computer‐generated random numbers schedule |
Allocation concealment? | Low risk | Centralised system |
Incomplete outcome data addressed? All outcomes | Unclear risk | Follow up based on extreme case scenario |